| Role |
Name |
Disclosure |
Details |
| Author | Bojan Paunovic, MD, Assistant Professor, Department of Internal Medicine, Section of Critical Care, University of Manitoba; Medical Director of Critical Care, Grace Hospital, Canada | Nothing to disclose | Details | | Coauthor | Sat Sharma, MD, FRCP(C), FCCP, FACP, DABSM, Program Director, Associate Professor, Department of Internal Medicine, Divisions of Pulmonary and Critical Care Medicine, University of Manitoba; Site Director of Respiratory Medicine, St Boniface General Hospital | Nothing to disclose | Details | | Medical Editor | Gregory Joseph Dehmer, MD, Director, Division of Cardiology, Professor, Department of Medicine, Scott & White Clinic, Texas A&M University School of Medicine | Nothing to disclose | Details | | Pharmacy Editor | Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine | Nothing to disclose | Details | | Managing Editor | Ronald J Oudiz, MD, Director of Pulmonary Hypertension, Associate Professor, Department of Medicine, Division of Cardiology, Harbor-UCLA Medical Center, David Geffen School of Medicine at UCLA | Actelion Encysive Gilead Pfizer United Therapeutics | Details | | CME Editor | Amer Suleman, MD, Consultant in Electrophysiology and Cardiovascular Medicine, Department of Internal Medicine, Division of Cardiology, Medical City Dallas Hospital | Nothing to disclose | Details | | Chief Editor | Karlheinz Peter, MD, PhD, Professor of Medicine, Monash University; Head of Centre of Thrombosis and Myocardial Infarction, Head of Division of Atherothrombosis and Vascular Biology, Associate Director, Baker Heart Research Institute; Consulting Staff, Department of Cardiology, Alfred Hospital | Nothing to disclose | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Amer Suleman, CME Editor |
The contributor discloses no conflict of interest. |
|